Related Experiment Video
Updated: Jul 16, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Factors influencing physicians' screening behavior for liver cancer among high-risk patients
Tung T Nguyen1, Ginny Gildengorin, Amy Truong
1Suc Khoe La Vang! (Health is Gold!), Vietnamese Community Health Promotion Project, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0320, USA. Tung.Nguyen@ucsf.edu
Background:
Little is known about physicians' screening patterns for liver cancer despite its rising incidence.
Objective:
Describe physician factors associated with liver cancer screening.
Design:
Mailed survey.
Participants:
Physicians practicing in family practice, internal medicine, gastroenterology, or nephrology in 3 northern California counties in 2004.
Measurements:
Sociodemographic and practice measures, liver cancer knowledge, attitudes, and self-reported screening behaviors.
Results:
The response rate was 61.8% (N = 459). Gastroenterologists (100%) were more likely than Internists (88.4%), family practitioners (84.2%), or nephrologists (75.0%) to screen for liver cancer in high-risk patients (p = 0.016). In multivariate analysis, screeners were more likely than nonscreeners to think that screening for liver cancer reduced mortality (odds ratio [OR] 1.60, CI 1.09-2.34) and that not screening was a malpractice risk (OR 1.88, CI 1.29-2.75). Screeners were more likely than nonscreeners to order any screening test if it was a quality of care measure (OR 4.39, CI 1.79-10.81).
Conclusions:
Despite debate about screening efficacy, many physicians screen for liver cancer. Their screening behavior is influenced by malpractice and quality control concerns. More research is needed to develop better screening tests for liver cancer, to evaluate their effectiveness, and to understand how physicians behave when there is insufficient evidence.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Cancer Prevention
Some...
Cancer Prevention
Some...